Related Experiment Videos
Prognostic importance of cognitive impairment in chronic heart failure patients: does specialist management make a
Skye N McLennan1, Sue A Pearson, Janette Cameron
1University of South Australia, Division of Health Science, Australia.
Insights
Mild cognitive impairment significantly increases mortality risk in chronic heart failure (CHF) patients. This prognostic importance persists even with a CHF management program (CHF-MP).
Area of Science:
- Cardiology
- Neurology
- Gerontology
Background:
- Cognitive impairment is a prevalent comorbidity in patients with chronic heart failure (CHF).
- The prognostic implications of cognitive impairment in CHF patients require further elucidation.
Purpose of the Study:
- To assess the prognostic significance of cognitive impairment in CHF patients enrolled in a randomized CHF management program (CHF-MP).
Main Methods:
- A randomized controlled trial comparing a CHF-MP (n=100) to usual care (n=100).
- Baseline cognitive function was evaluated using the Mini Mental Status Examination (MMSE).
- Five-year all-cause mortality and death-or-readmission rates were compared between patients with and without cognitive impairment (MMSE 19-26 vs. >26).
Main Results:
- 13.5% of CHF patients exhibited cognitive impairment (MMSE 19-26).
- Cognitively impaired patients had a significantly higher adjusted risk of all-cause mortality (RR 2.19, P<0.001) and unplanned hospitalization (RR 1.44, P=0.019).
- While not significant overall, the CHF-MP mitigated the increased risk of death-or-readmission for cognitively impaired patients compared to usual care. However, within the CHF-MP, cognitively impaired patients still showed a significantly higher adjusted risk of death (RR 2.33, P=0.027).
Conclusions:
- Mild cognitive impairment (MMSE 19-26) is a significant prognostic indicator in CHF patients.
- The prognostic impact of cognitive impairment persists even when patients receive a CHF management program.
- Further research may explore tailored interventions for cognitively impaired CHF patients.
Background:
Cognitive impairment is common among chronic heart failure (CHF) patients.
Aims:
To determine the prognostic significance of cognitive impairment in patients participating in a randomized study of a CHF management program (CHF-MP).
Methods:
CHF patients were randomized to a CHF-MP (n=100) or usual care (n=100). Baseline cognition was assessed using the Mini Mental Status Examination (MMSE). Five-year all-cause mortality, and combined death-or-readmission, were compared on the basis of the presence (MMSE 19-26) or absence (MMSE >26) of cognitive impairment.
Results:
27 patients (13.5%) had cognitive impairment and, on an adjusted basis, were more likely to die (96.3% versus 68.2%. RR 2.19, 95% CI 1.41 to 3.39: P<0.001) and/or experience an unplanned hospitalization (100% versus 94%. RR 1.44, 95% CI 1.06 to 1.95: P=0.019). Cognitively impaired patients had a similar (non-significant) adjusted risk of death-or-readmission in both the CHF-MP (RR 1.40, 95% CI 0.63 to 3.11: P=0.403) and in usual care (RR 1.38, 95% CI 0.75 to 2.53: P=0.305). In the usual care cohort, cognitive impairment was associated with a greater (non-significant), adjusted risk of death (RR 1.61, 95% CI 1.10 to 4.92: P=0.122). In the CHF-MP, adjusted risk of death was significantly higher for cognitively impaired patients (RR 2.33, 95% CI 1.10 to 4.92: P=0.027).
Conclusion:
These data suggest that "mild" cognitive impairment is of prognostic importance in CHF: even when a CHF-MP has been applied.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
Heart Failure VII: Nursing Interventions
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management